Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
15.05.2019 18:00:00

NEURONES : +4.2% organic growth in the 1st quarter 2019

PRESS INFORMATION
Nanterre, 15 May 2019 (after the closing of the stock exchange)
Heading: Revenues 1st quarter 2019

+4.2% organic growth in the 1st quarter 2019

(in millions of euros)Q1 2018Q1 2019growthof which organic
Revenues (¹)124.1128.7+3.7%+4.2%

Achievements

In the first quarter of 2019, the Group achieved 4.2% organic growth. Over the period, after the high point for financial year 2018, employee turnover began to decline.

The operating profit (¹) (²) for the quarter totaled 9.5% of revenues vs. 8.4% one year earlier.

Compared to the 2018 reference document (available at www.neurones.net), the financial situation did not experience any significant changes.

Outlook

In its current scope, NEURONES forecasts the following for 2019:

  • close to €505 million in revenues,
  • an operating profit (²) of between 9% and 9.5% of revenues.

(¹) Unaudited and after inclusion of 0.1% expenses related to bonus shares.
(²) These figures do not include the consolidated capital gain (+ €4.6 million) realized at the end of January 2019, on the occasion of the sale of an activity representing annual revenues of €5.3 million. The operating profit (IFRS) for the 1st quarter is therefore 13% and the forecast for financial year 2019 is increased by approximately 0.9% of revenues.

About NEURONES

With 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and Digital Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
www.neurones.net

 Investor Relations:
NEURONES
Paul-César Bonnel
Tel: +33 (0)1 41 37 41 37
investisseurs@neurones.net
Press Relations:
NEURONES
Matthieu Vautier
Tel: +33 (0)1 41 37 41 37
rp@neurones.net

Attachment

Nachrichten zu NeuronesAct.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu NeuronesAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

NeuronesAct. 44,10 2,20% NeuronesAct.